Tg Therapeuticscmn (TGTX)

$17.36 0.61 (3.39%)

16:00 EST TGTX Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 19, 2022

Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!

3 Small-Cap Stocks Ready for Big Growth

The 3 Best Biotech Stocks to Own in 2020

7 Killer Stock Picks for the Second Half of 2018

Volume:

Previous Close -

Market Cap 2.52B

PE Ratio -11.81

EPS -1.47

Volume (Avg. Vol.) 4.34M

Day's Range $17.11 - $18.31

52-Week Range $3.48 - $18.31

Dividend & Yield N/A (N/A)

TGTX Stock Predictions, Articles, and Tg Therapeuticscmn News

From InvestorPlace
From the Web

The 7 Best Stocks From Each Sector of Q1

By Harriet Lefton, Writer, TipRanks Mar 26, 2018

Which stocks really blossomed in the first quarter of 2018? Here I single out the seven best-performing stocks of Q1 -- one from each sector. Looking forward, I turn to the Street to assess whether these seven picks still make compelling investing opportunities.

5 ‘Strong Buy’ Biotechs That Can Double in 2018

By Harriet Lefton, Writer, TipRanks Mar 14, 2018

Here are five 'Strong Buy' biotech stocks with potential upside of over 100%. These five innovative stocks are worth tracking over the coming months according to the Street.

7 Hot Healthcare Stocks Set to Double in 2018

By Harriet Lefton, Writer, TipRanks Dec 26, 2017

These seven healthcare stocks have full marks from the Street. Here's a closer look at what makes these stocks so special.

TG Therapeutics Inc (TGTX) Stock Soars on Leukemia Drug Study Results

By Karl Utermohlen, InvestorPlace Writer Mar 6, 2017

TG Therapeutics Inc (TGTX) shares skyrocketed more than 80% Monday as one of the company's drugs reached a new Phase III target and FDA approval may be next.

22 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 11, 2016

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

19 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 4, 2016

The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").